The efficacy of mindfulness‐based cognitive therapy to improve depression symptoms and quality of life in individuals with memory difficulties and caregivers: A short report
Lana J. Ozen, Sacha Dubois, Megan M. English, Carrie Gibbons, Hillary Maxwell, Jessica Lowey, Erica Sawula, Michel Bédard
Alzheimer’s & Dementia: Translational Research & Clinical Interventions December 27, 2022 DOI: 10.1002/trc2.12252 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Older adults with memory difficulties and their caregivers |
| Topics | Depression Meditation |
| Keywords | Caregivers Cognitive impairment Cognitive therapy Memory |
| Key findings | MBCT did not significantly affect depression, anxiety, or mindfulness outcomes, but improvements in non-judgmental awareness correlated with reduced depression symptoms in both groups. |
Abstract
Abstract Introduction Depression symptoms are common for older adults with memory difficulties and their caregivers. Mindfulness‐based cognitive therapy (MBCT) reduces the risk of relapse in recurrent depression and improves depression symptoms. We explored recruitment and retention success and preliminary effect sizes of MBCT on depression and anxiety symptoms, as well as mindfulness facets, in individuals with memory difficulties and their caregivers.
Methods: A difficulty with memory group (DG) and caregiver group (CG) were randomized into either the MBCT intervention or waitlist control. After serving as controls, participants received the intervention. Mean pre–post changes by group were compared and effect sizes computed. Correlations between mindfulness facets and depression symptoms are also presented.
Results: Only 47% of the initial participants completed the study. The intervention did not have an effect on the outcome variables examined. However, improvements in non‐judgmental scores were associated with reductions in the number of depression symptoms reported by DG participants (r = –0.90, 95% confidence interval [CI]: –0.98, –0.52) and CG participants (r = –0.76, 95% CI: –0.95, –0.19). Furthermore, improvements in awareness scores (r = –0.69, 95% CI: –0.93, –0.05) and level of burden (r = 0.87, 95% CI: 0.49, 0.97) also significantly correlated with reduced depression symptoms in the CG group.
Conclusions: By determining preliminary MBCT effect sizes in individuals with memory difficulties and their caregivers, research with larger, controlled samples is now justified to determine the true effects of MBCT in these populations.